Evidence map›Paper›PMID 34299230›Full record

ArticleInternational journal of molecular sciences2021

Knockout of NPFFR2 Prevents LPS-Induced Depressive-Like Responses in Mice.

Zachary Yu, Ya-Tin Lin, Jin-Chung Chen

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Neural plasticity and depression treatment.IBRO neuroscience reports · 2023
    Article
  4. Review
  5. Article
  6. Anxiety and Depression: What Do We Know of Neuropeptides?Behavioral sciences (Basel, Switzerland) · 2022
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Zachary YuDepartment of Medicine, Chang Gung University, Taoyuan 333, Taiwan.
Ya-Tin LinDepartment of Physiology and Pharmacology, Graduate Institute of Biomedical Sciences, Chang Gung University, Taoyuan 333, Taiwan.ORCID 0000-0001-7910-1223
Jin-Chung ChenDepartment of Physiology and Pharmacology, Graduate Institute of Biomedical Sciences, Chang Gung University, Taoyuan 333, Taiwan.ORCID 0000-0003-2996-5781
Chang Gung University · TW

Funding

Chang Gung Memorial Hospital CMRPD1H0433Healthy Aging Research Center, Chang Gung University EMRPD1K0361Ministry of Science and Technology, Taiwan MOST 107-2320-B-182 -019-MY3
6 · The paper itself

Abstract

The precise neural mechanisms underlying the pathogenesis of depression are largely unknown, though stress-induced brain inflammation and serotonergic plasticity are thought to be centrally involved. Moreover, we previously demonstrated that neuropeptide FF receptor 2 (NPFFR2) overexpression provokes depressive-like behaviors in mice. Here, we assess whether NPFFR2 is involved in priming of depressive-like behaviors and downregulation of serotonergic 1A receptor (5HT1AR) after lipopolysaccharide (LPS) treatment. The forced swimming test (FST) and sucrose preference test (SPT) were used to quantify depressive-like phenotypes in wild-type (WT) and NPFFR2-knockout (KO) mice. A single dose of LPS (i.p. 1 mg/kg) readily caused increases in toll-like receptor 4 and tumor necrosis factor-α along with decreases in 5-HT1AR mRNA in the ventral hippocampus of WT mice. Furthermore, LPS treatment of WT mice increased immobility time in FST and decreased sucrose preference in SPT. In contrast, none of these effects were observed in NPFFR2-KO mice. While WT mice injected with lentiviral 5-HT1AR shRNA in the ventral hippocampus displayed an unaltered response after LPS challenge, LPS-challenged NPFFR2-KO mice displayed a profound decrease in sucrose preference when pretreated with 5-HT1AR shRNA. Taken together, these results suggest that NPFFR2 modulates LPS-induced depressive-like behavioral phenotypes by downregulating 5HT1AR in the ventral hippocampus.

Indexed as

AnimalsBehavior, AnimalDepressionDisease Models, AnimalFemaleHippocampusLipopolysaccharidesMiceMice, Inbred C57BLMice, KnockoutMotor ActivityReceptor, Serotonin, 5-HT1AReceptors, NeuropeptideToll-Like Receptor 4Tumor Necrosis Factor-alphaHtr1a protein, mouseLipopolysaccharidesneuropeptide FF receptorReceptor, Serotonin, 5-HT1AReceptors, NeuropeptideTlr4 protein, mouseToll-Like Receptor 4Tumor Necrosis Factor-alphadepressionLPSneuropeptide FFNPFFR2serotonin 1A receptor (5-HT1AR)

Identifiers

PMID34299230
PMCPMC8306864
OpenAlexW3185808051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.